Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
BMJ Open
|
March 30, 2012
A qualitative evaluation of general practitioners' perceptions regarding access to medicines in New Zealand
Zaheer-Ud-Din Babar, Piyush Grover, Rachael Butler, et al.
Endocrine-Related Cancer
|
May 19, 2021
Long-term hematologic toxicity of 177Lu-octreotate-capecitabine-temozolomide therapy of GEPNET
Murali Kesavan, Piyush Grover, Wei-Sen Lam, et al.
BMC Cancer
|
October 11, 2025
A two-phase study investigating the quality of life benefit of additional 0.5% cocaine mouthwash to institutional standard of care mucositis management in head and neck cancer patients undergoing radiotherapy or chemoradiotherapy
Piyush Grover, Colin Tang, Angela Jacques, et al.
Research in Social & Administrative Pharmacy : RSAP
|
January 29, 2011
Evaluating pharmacists' views, knowledge, and perception regarding generic medicines in New Zealand
Zaheer-Ud-Din Babar, Piyush Grover, Joanna Stewart, et al.
Internal Medicine Journal
|
November 20, 2021
Clinicopathological characteristics and clinical morbidity in high-risk head and neck cutaneous squamous cell carcinoma patients in Western Australia
Piyush Grover, Stephanie Flukes, Angela Jacques, et al.
Plos Genetics
|
May 24, 2008
BRCA1 and BRCA2 missense variants of high and low clinical significance influence lymphoblastoid cell line post-irradiation gene expression
Nic Waddell, Anette Ten Haaf, Anna Marsh, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 14, 2024
Anti-PD-(L)1 plus BRAF/MEK inhibitors (triplet therapy) after failure of immune checkpoint inhibition and targeted therapy in patients with advanced melanoma
Lea Jessica Albrecht, Florentia Dimitriou, Piyush Grover, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 8, 2024
Treatment sequence with tebentafusp and immune checkpoint inhibitors in patients with metastatic uveal melanoma and metastatic GNA11/GNAQ mutant melanocytic tumors
Florentia Dimitriou, Marlana M Orloff, Erica C Koch Hein, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 26, 2024
Outcomes of patients with resected stage III/IV acral or mucosal melanoma, treated with adjuvant anti-PD-1 based therapy
Sarah K Jacques, Janet McKeown, Piyush Grover, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
BMJ Open
|
March 30, 2012
A qualitative evaluation of general practitioners' perceptions regarding access to medicines in New Zealand
Zaheer-Ud-Din Babar, Piyush Grover, Rachael Butler, et al.
Endocrine-Related Cancer
|
May 19, 2021
Long-term hematologic toxicity of 177Lu-octreotate-capecitabine-temozolomide therapy of GEPNET
Murali Kesavan, Piyush Grover, Wei-Sen Lam, et al.
BMC Cancer
|
October 11, 2025
A two-phase study investigating the quality of life benefit of additional 0.5% cocaine mouthwash to institutional standard of care mucositis management in head and neck cancer patients undergoing radiotherapy or chemoradiotherapy
Piyush Grover, Colin Tang, Angela Jacques, et al.
Research in Social & Administrative Pharmacy : RSAP
|
January 29, 2011
Evaluating pharmacists' views, knowledge, and perception regarding generic medicines in New Zealand
Zaheer-Ud-Din Babar, Piyush Grover, Joanna Stewart, et al.
Internal Medicine Journal
|
November 20, 2021
Clinicopathological characteristics and clinical morbidity in high-risk head and neck cutaneous squamous cell carcinoma patients in Western Australia
Piyush Grover, Stephanie Flukes, Angela Jacques, et al.
Plos Genetics
|
May 24, 2008
BRCA1 and BRCA2 missense variants of high and low clinical significance influence lymphoblastoid cell line post-irradiation gene expression
Nic Waddell, Anette Ten Haaf, Anna Marsh, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 14, 2024
Anti-PD-(L)1 plus BRAF/MEK inhibitors (triplet therapy) after failure of immune checkpoint inhibition and targeted therapy in patients with advanced melanoma
Lea Jessica Albrecht, Florentia Dimitriou, Piyush Grover, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 8, 2024
Treatment sequence with tebentafusp and immune checkpoint inhibitors in patients with metastatic uveal melanoma and metastatic GNA11/GNAQ mutant melanocytic tumors
Florentia Dimitriou, Marlana M Orloff, Erica C Koch Hein, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 26, 2024
Outcomes of patients with resected stage III/IV acral or mucosal melanoma, treated with adjuvant anti-PD-1 based therapy
Sarah K Jacques, Janet McKeown, Piyush Grover, et al.
Page
of 2